<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chadchan SB</submitter><funding>NICHD NIH HHS</funding><funding>NCI NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development</funding><pagination>28</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9873805</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(1)</volume><pubmed_abstract>Endometriosis is a pathological condition of the female reproductive tract characterized by the existence of endometrium-like tissue at ectopic sites, affecting 10% of women between the age 15 and 49 in the USA. However, currently there is no reliable non-invasive method to detect the presence of endometriosis without surgery and many women find hormonal therapy and surgery as ineffective in avoiding the recurrences. There is a lack of knowledge on the etiology and the factors that contribute to the development of endometriosis. A growing body of recent evidence suggests an association between gut microbiota and endometriosis pathophysiology. However, the direct impact of microbiota and microbiota-derived metabolites on the endometriosis disease progression is largely unknown. To understan</pubmed_abstract><journal>Cell death discovery</journal><pubmed_title>Gut microbiota and microbiota-derived metabolites promotes endometriosis.</pubmed_title><pmcid>PMC9873805</pmcid><funding_grant_id>R01HD065435</funding_grant_id><funding_grant_id>R00HD080742</funding_grant_id><funding_grant_id>R01 CA220297</funding_grant_id><funding_grant_id>R01 CA216426</funding_grant_id><funding_grant_id>R00 HD080742</funding_grant_id><funding_grant_id>R01 HD065435</funding_grant_id><funding_grant_id>P30 CA125123</funding_grant_id><funding_grant_id>R01 HD102680</funding_grant_id><funding_grant_id>R01HD102680</funding_grant_id><pubmed_authors>Kommagani R</pubmed_authors><pubmed_authors>Putluri S</pubmed_authors><pubmed_authors>Ambati CR</pubmed_authors><pubmed_authors>Kau AL</pubmed_authors><pubmed_authors>Stallings CL</pubmed_authors><pubmed_authors>Naik SK</pubmed_authors><pubmed_authors>Popli P</pubmed_authors><pubmed_authors>Lint MA</pubmed_authors><pubmed_authors>Talwar C</pubmed_authors><pubmed_authors>Chadchan SB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Gut microbiota and microbiota-derived metabolites promotes endometriosis.</name><description>Endometriosis is a pathological condition of the female reproductive tract characterized by the existence of endometrium-like tissue at ectopic sites, affecting 10% of women between the age 15 and 49 in the USA. However, currently there is no reliable non-invasive method to detect the presence of endometriosis without surgery and many women find hormonal therapy and surgery as ineffective in avoiding the recurrences. There is a lack of knowledge on the etiology and the factors that contribute to the development of endometriosis. A growing body of recent evidence suggests an association between gut microbiota and endometriosis pathophysiology. However, the direct impact of microbiota and microbiota-derived metabolites on the endometriosis disease progression is largely unknown. To understan</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-04T13:07:40.194Z</modification><creation>2025-04-04T13:07:40.194Z</creation></dates><accession>S-EPMC9873805</accession><cross_references><pubmed>36693853</pubmed><doi>10.1038/s41420-023-01309-0</doi></cross_references></HashMap>